Imunon (IMNN)
NASDAQ:IMNN
Total Valuation
Imunon has a market cap or net worth of $12.24M. The enterprise value is $118.38K.
Market Cap$12.24M
Enterprise Value$118.38K
Share Statistics
Imunon has 3,922,764 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,922,764
Owned by Insiders11.04%
Owned by Institutions10.59%
Financial Efficiency
Imunon’s return on equity (ROE) is -2.05 and return on invested capital (ROIC) is -172841.93%.
Return on Equity (ROE)-2.05
Return on Assets (ROA)-1.18
Return on Invested Capital (ROIC)-172841.93%
Return on Capital Employed (ROCE)-1.91K
Revenue Per Employee0.00
Profits Per Employee-579.80K
Employee Count25
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Imunon is ―. Imunon’s PEG ratio is 0.00825.
PE Ratio―
PS Ratio0.00
PB Ratio1.15
Price to Fair Value1.15
Price to FCF>-0.01
Price to Operating Cash Flow<0.01
PEG Ratio0.00825
Income Statement
In the last 12 months, Imunon had revenue of 0.00 and earned -14.49M in profits. Earnings per share was -6.83.
Revenue0.00
Gross Profit0.00
Operating Income-14.65M
Pretax Income-14.50M
Net Income-14.49M
EBITDA-13.95M
Earnings Per Share (EPS)-6.83
Cash Flow
In the last 12 months, operating cash flow was -13.90M and capital expenditures -280.57K, giving a free cash flow of -14.18M billion.
Operating Cash Flow-13.90M
Free Cash Flow-14.18M
Free Cash Flow per Share-3.61
Dividends & Yields
Imunon pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.44
52-Week Price Change-72.50%
50-Day Moving Average3.16
200-Day Moving Average4.96
Relative Strength Index (RSI)53.19
Average Volume (3m)145.76K
Important Dates
Imunon upcoming earnings date is May 18, 2026, TBA (Confirmed).
Last Earnings DateMar 31, 2026
Next Earnings DateMay 18, 2026
Ex-Dividend Date―
Financial Position
Imunon as a current ratio of 2.32, with Debt / Equity ratio of 14.27%
Current Ratio2.32
Quick Ratio2.32
Debt to Market Cap0.12
Net Debt to EBITDA0.56
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Imunon has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Imunon EV to EBITDA ratio is -0.02, with an EV/FCF ratio of >-0.01.
EV to Sales0.00
EV to EBITDA-0.02
EV to Free Cash Flow>-0.01
EV to Operating Cash Flow>-0.01
Balance Sheet
Imunon has $8.78M in cash and marketable securities with $1.01M in debt, giving a net cash position of $7.77M billion.
Cash & Marketable Securities$8.78M
Total Debt$1.01M
Net Cash$7.77M
Net Cash Per Share$1.98
Tangible Book Value Per Share$3.33
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Imunon is $18.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$18.50
Price Target Upside492.95% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast57.97%